Associated Papers
Human genetic variation reveals FCRL3 is a lymphocyte receptor for Yersinia pestis.
Keener RM et al.
Biorxiv : the Preprint Server for Biology, 2024
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
Goetz MP et al.
Journal of the National Cancer Institute, 2017
28376176 (PubMed )
Supplement: djw306_Supp.zip › 16-0785R2_Goetz_Supplementary_Tables_3-6_111716.xlsx › Suppl_Table_5a
Select a paper to view details